脂蛋白促进表观遗传重编程,通过稳定BRD2促进质母细胞瘤的生长
Lishu Chen1, Qinghui Qi1, Xiaoqing Jiang2,3
1Nanhu Laboratory, National Center of Biomedical Analysis, Beijing, China.
Cancer discovery
|April 2, 2024
概括
质母细胞的干细胞产生脂蛋白 (PCr) 来保护BRD2蛋白,促进瘤的生长. 通过循环创造蛋白抑制PCr生成,可以阻止质母细胞瘤的生长,并提高BRD2抑制剂的有效性.
科学领域:
- 在瘤学瘤学.
- 代谢研究研究 代谢研究
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 质母细胞瘤 (GBM) 具有显著的代谢适应性,有助于其生存和对治疗的耐药性.
- 驱动GBM代谢可塑性和治疗耐药性的精确机制尚未完全理解.
研究的目的:
- 阐明酸蛋白 (PCr) 生产在GBM干细胞重编程和治疗耐药性中的作用.
- 调查针对PCr生物合成作为GBM治疗策略的潜力.
主要方法:
- 对GBM干细胞代谢和表观遗传修饰的分析.
- 调查PCr,指E盒结合本源盒1和含蛋白2 (BRD2) 之间的相互作用.
- 在临床前的GBM模型中,利用循环创造蛋白 (cCr) 来破坏PCr生物合成.
主要成果:
- GBM干细胞通过增加大脑类型肌酸激酶转录来提高PCr的产生,这种转录由指E-box结合homeobox1介导.
- 通过与E3结合酶SPOP竞争,PCr可以抑制BRD2的泛化和降解.
- 在小鼠模型中,循环创造蛋白治疗导致BRD2降解,细胞增殖减少,并显著抑制瘤生长.
- 在GBM模型中,循环创造氨酸增强了BRD2抑制剂的疗效,没有观察到副作用.
结论:
- 高PCr产生是GBM中一个关键的,可用药物的代谢漏洞.
- 向PCr生物合成是治疗质母细胞瘤治疗的一个有希望的治疗途径.
- 破坏PCr代谢会影响表观遗传调节和细胞分裂,为抗 GBM 提供了一种新的策略.
更多相关视频
10:28Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
Published on: January 10, 2018
8.3K
09:18Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds
Published on: July 16, 2018
8.3K
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Protein Kinases and Phosphatases
13.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.1K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
